PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026Neuropsychopharmacology Reports0 citationsOpen Access

A Preliminary Open‐Label Pilot Study of a Pillow‐Based ELF ‐ ELME (Extremely Low‐Frequency, Extremely Low Magnetic Environment) Intervention for Major Depressive Disorder

View Full Paper
ITIbuki TomitaMTM. TachibanaYNYoshihiro Nawa

Key Points

  • This study investigates the efficacy and safety of a pillow-based ELF-ELME intervention in alleviating depressive symptoms in patients diagnosed with major depressive disorder.
  • Open-label pilot study design with four patients
  • Intervention consisted of a pillow-based ELF-ELME device for 2 hours daily over 8 weeks
  • Assessment of MADRS and AI-MADRS scores to evaluate effectiveness
  • Total MADRS scores decreased from 33.8 ± 7.3 to 21.5 ± 8.7 (p = 0.050, FDR = 0.067) over 8 weeks
  • AI-MADRS scores significantly decreased from 34.0 ± 8.3 to 19.8 ± 6.8 (p = 0.040)
  • No serious adverse events reported during the study.

Abstract

ABSTRACT Background Mitochondrial dysfunction has been implicated in the pathogenesis of depression. Major depressive disorder (MDD) is a prevalent condition with substantial individual and societal burden. A novel approach—exposure to an extremely low‐frequency, extremely low magnetic environment (ELF‐ELME)—has shown promise. This preliminary study builds on a previous trial using a head‐mounted ELF‐ELME device and explores the potential efficacy and safety of a pillow‐based ELF‐ELME device in patients with MDD. Methods In this preliminary open‐label pilot study, four patients with MDD were treated using a pillow‐based ELF‐ELME device (10 μTesla, 4 ms, 1–8 Hz/8 s) for 2 h daily over 8 weeks. The primary outcome was change in Montgomery–Åsberg Depression Rating Scale (MADRS) scores from baseline to Week 8. Artificial Intelligence‐based MADRS (AI‐MADRS) scores were also assessed. Results Total MADRS scores showed a unidirectional decrease from baseline (33.8 ± 7.3) to Week 8 (21.5 ± 8.7; p = 0.050, FDR = 0.067), and no time point reached statistical significance after FDR correction. In contrast, AI‐MADRS scores significantly decreased from baseline (34.0 ± 8.3) to Week 8 (19.8 ± 6.8; p = 0.040). No serious adverse events were reported. Conclusion These preliminary findings suggest that an 8‐week course of pillow‐based ELF‐ELME intervention may have potential to alleviate depressive symptoms in patients with MDD. However, given the small sample size and open‐label design, the results should be interpreted with caution. Larger controlled studies are warranted to confirm these findings. Trial Registration jRCT number: jRCTs042240061; https://jrct.mhlw.go.jp/en‐latest‐detail/jRCTs042240061

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tomita et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc5b7dee9eb8c0dce7123https://doi.org/10.1002/npr2.70139
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX)2024
  2. 2Acute Treatment of 60‐Hz Electric Field Increases Parasympathetic Activity in Depressed Subjects: A Pilot Study Using Heart Rate Variability Analysis2024 · 1 citations
  3. 3Reward System EEG–fMRI-Pattern Neurofeedback for Major Depressive Disorder with Anhedonia: A Multicenter Pilot Study2025 · 3 citations
  4. 4Exploring the feasibility, safety and preliminary clinical effects of amygdala-targeted temporal interference stimulation for major depressive disorder: a pilot study2026
  5. 5306. EMOTIONAL FACES MEMORY TASK PERFORMANCE AND CLINICAL OUTCOMES FOR THE NOVEL PRESCRIPTION DIGITAL THERAPEUTIC, CT-1522025